Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
#Events

Category: Uncategorized

In Vivo Cell Therapy Breakthrough: Johnson & Johnson Commits $785 Million Upfront to Sail Biomedicines, Securing a $2.58 Billion Acquisition Option for Autoimmune CAR-T Platform

04/08/2026 Published by Pharma Biz

Key Development Global healthcare leader Johnson & Johnson (NYSE: JNJ) has formally executed a strategic collaboration and equity investment agreement... Read more

Tags: #M&A

Resolving Legacy Generic Price-Fixing Exposure: Sandoz Agrees to $480 Million Settlements to Conclude All US Federal, State, and Class-Action Antitrust Claims

04/08/2026 Published by Pharma Biz

Key Development Basel-headquartered generic and biosimilar pharmaceuticals leader Sandoz Group AG has formally entered into definitive settlement agreements totaling approximately... Read more

Category: Uncategorized

Tags: #Global Trends

Mega Radiopharmaceutical Merger: Curium Strikes $8 Billion Deal to Acquire Rival Lantheus, Building a Global Theranostics Powerhouse

04/08/2026 Published by Pharma Biz

Key Development Leading global private radiopharmaceutical manufacturer Curium Group (backed by private equity firm CapVest Partners) has formally entered into... Read more

Category: Uncategorized

Tags: #M&A

Targeted Radiopharmaceuticals Expansion: Ratio Therapeutics Secures $70 Million Series C Financing Backed by Eli Lilly and Bristol Myers Squibb

04/08/2026 Published by Pharma Biz

Key Development U.S. clinical-stage radiopharmaceutical developer Ratio Therapeutics has officially closed a $70 million Series C financing round. The oversubscribed... Read more

Category: Uncategorized

Tags: #Global Trends

Life Sciences Cyber Crisis: Amgen Suffers Third-Party Cloud Breach, Exposing Protected Patient Health Information and Proprietary R&D Data

04/08/2026 Published by Pharma Biz

Key Development American biotechnology major Amgen Inc. (NASDAQ: AMGN) has formally filed a Form 8-K disclosure with the U.S. Securities... Read more

Category: Uncategorized

Tags: #Global Trends

Neuroscience Consolidation: Supernus and Indivior Agree to All-Stock Merger Creating a $2.2 Billion CNS Biopharma Powerhouse

04/08/2026 Published by Pharma Biz

Key Development U.S. commercial biopharmaceutical specialists Supernus Pharmaceuticals (NASDAQ: SUPN) and Indivior Pharmaceuticals (NASDAQ: INDV) have formally entered into a... Read more

Category: Uncategorized

Tags: #M&A

Billion-Dollar MedTech Buyout: KKR Executes $5.7 Billion All-Cash Take-Private Transaction for Integer Holdings

04/08/2026 Published by Pharma Biz

Key Development Global private equity powerhouse KKR & Co. (NYSE: KKR) has formally entered into a definitive merger agreement to... Read more

Category: Uncategorized

Tags: #M&A

Next-Gen Obesity Therapeutics: Eli Lilly Launches Early Access Program for Experimental Triple-Agonist Retatrutide Ahead of FDA Submission

04/08/2026 Published by Pharma Biz

Key Development American pharmaceutical leader Eli Lilly and Co. (NYSE: LLY) has confirmed the launch of an Expanded Access Program... Read more

Category: Uncategorized

Tags: #Global Trends

Corporate Governance Shift in Domestic Pharma: 24-Year-Old Daughter of Nam A Bank Chairman Appointed Deputy CEO of Ben Tre Pharmaceutical (DBT)

04/08/2026 Published by Pharma Biz

Key Development Ben Tre Pharmaceutical Joint Stock Company (HOSE Ticker: DBT) has officially ratified resolutions from its Extraordinary General Meeting... Read more

Category: Uncategorized

Tags: #Vietnam

Posts pagination

Previous page Page 1 … Page 18 Page 19 Page 20 … Page 200 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members